Search All News
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
Columbia expert Dr. Fatemeh Momen-Heravi shares facts about HPV-related cancer risk factors and prevention.
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
- March 17, 2022
In the future, bacteria may be let loose in the body to seek and destroy cancer cells, but the bacteria need a way to hide from our immune system. Columbia biomedical engineers may have a solution.
- March 17, 2022
In the early days of Columbia's cancer program, several incredible women physicians and scientists made key discoveries in the field.
- March 7, 2022
Having a rapport with kids is a critical part of the job for James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
- March 3, 2022
Lung cancer often spreads to the brain. Columbia scientists have now uncovered a tactic used by metastases to hide in the brain and identified a drug combination that can potentially target them.
- February 22, 2022
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
- February 4, 2022
A clinical trial led by a Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.
- January 27, 2022
Active surveillance has emerged as a safe option for some thyroid cancers, illustrating that less can be more in thyroid cancer management.
- January 25, 2022
Columbia cancer researchers are developing virtual reality technology to visualize and explore cancer tumors and gain new insights.
- January 24, 2022
Barbara Pro, MD, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at Columbia University's Herbert Irving Comprehensive Cancer Center.
- January 19, 2022
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.